Not finding it? Sign in to also search OpenAlex live.
-
AB0892 SMOKING DOES NOT REPRESENT A SUSCEPTIBILITY FACTOR FOR THE DEVELOPMENT OF SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE LEIDEN CCISS COHORT2023 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Sclerosis and Related Diseases Open access
Jacopo Ciaffi, Sophie I E Liem, Tom W. J. Huizinga, Jeska de Vries‐Bouwstra
0citations -
ABS0815 EFFICACY AND SAFETY OF TOFACITINIB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS NAÏve TO BIOLOGIC OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
S. Ramiro, Lídia Sànchez-Riera, Mary Jane Cadatal, M. Montoro
0citations -
Apply-PNH: Analysis of complement pathway biomarkers provides evidence for pharmacodynamic response in PNH patients who receive oral iptacopan monotherapy versus continuing anti-C5 therapy2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Richard Kelly, Austin Gladston Kulasekararaj, Alexander Röth, Phillip Scheinberg, Yasutaka Ueda, +4 more
0citations -
ABS0718 AGE AS THE MAIN PREDICTOR FOR RHEUMATOID ARTHRITIS INITIAL TREATMENT: A MACHINE LEARNING ANALYSIS USING DATA FROM METEOR REGISTRY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
David Vega‐Morales, Sytske Anne Bergstra, A Chopra, Wendy Marisol Orzúa-de la Fuente, Elsa Vieira‐Sousa, Nimmisha Govind
0citations -
Oral iptacopan monotherapy demonstrates clinically meaningful hemoglobin increases in patients with paroxysmal nocturnal hemoglobinuria with baseline hemoglobin levels 10 to <12 g/dl on anti-C5 therapy: Subgroup analysis of the appulse-pnh Phase 3b trial2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Austin Gladston Kulasekararaj, Flore Sicre-de-Fontbrune, Anna Gayà, Ilene Ceil Weitz, David J. Kuter, David J. Araten, +15 more
0citations -
OP0230 EFFICACY AND SAFETY OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO DEMONSTRATED INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION: WEEK 24 RESULTS OF A PHASE 3B, RANDOMIZED, CONTROLLED STUDY2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Laura C. Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S. Karyekar, +4 more
4citations -
OP0019 STABLE VERSUS TAPERED AND WITHDRAWN TREATMENT WITH TUMOR NECROSIS FACTOR INHIBITOR IN RHEUMATOID ARTHRITIS REMISSION (ARCTIC REWIND): A RANDOMISED, OPEN-LABEL, PHASE 4, NON-INFERIORITY TRIAL2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga, J. Sexton, Inge Christoffer Olsen, Åse Stavland Lexberg, +13 more
2citations -
OP0035 WHAT EXPLAINS THE WORLDWIDE GRADIENT OF AGE AT ONSET OF RHEUMATOID ARTHRITIS ALONG LATITUDE? A MULTILEVEL ANALYSIS IN THE METEOR REGISTRY2022 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Sytske Anne Bergstra, A. Sepriano, A. Chopra, Lai Ling Winchow, David Vega‐Morales, K. Solomon-Escoto, +2 more
0citations -
ABS0645 TREATMENT PATTERNS AND DETERMINANTS OF DMARD SWITCHING IN EUROPEAN RHEUMATOID ARTHRITIS COHORTS: A MULTI-NATIONAL ANALYSIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
D. Di Giuseppe, Nils Steinz, J. Sexton, C.A. Hana, H. Lechner-Radner, D. Sieghart, +3 more
0citations -
Abstract 1727: CD8+ T cells in the invasive margin combined with FOXP3+ T cells in the tumor center significantly associate with survival in resectable gastric cancer, a post-hoc analysis of the Dutch D1/D2 trial
Tanya T.D. Soeratram, Hedde D. Biesma, Jacqueline Egthuijsen, Elma Meershoek‐Klein Kranenbarg, Henk H. Hartgrink, Cornelis JH van de Velde, +5 more
0citations -
Longer-term safety of pimicotinib in tenosynovial giant cell tumor (TGCT): Integrated analysis of phase 1 and phase 3 MANEUVER trial data.2026 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments
Hans A. J. Gelderblom, Vinod Ravi, Vishal Ghori, Aimar Zhang, Niki Karachaliou, Boyao Shan, +2 more
0citations -
Postpartum Hemorrhage in Women with Von Willebrand Disease after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)
Anne de Vaan, Jeroen C.J. Eikenboom, Marieke J.H.A. Kruip, Marieke C. Punt, Michiel Coppens, Laurens Nieuwenhuizen, +10 more
2citations -
Postpartum Hemorrhage in Hemophilia a and B Carriers after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)
Anne de Vaan, Marieke J.H.A. Kruip, Jeroen C.J. Eikenboom, Marieke C. Punt, Michiel Coppens, Laurens Nieuwenhuizen, +10 more
5citations -
SURG-83. Inter-rater agreement from an international expert panel on resectability of recurrent glioblastoma: a complementary post-hoc analysis of the prospective, randomized DIRECTOR trial
Philipp Karschnia, Nico Teske, Émilie Le Rhun, Hans‐Georg Wirsching, Asgeir Store Jakola, Constantin Roder, +12 more
0citations -
Prognostic Interaction Between Inflammatory and Clinical Risk Factors for Asthma Attacks: Findings from the ORACLE2 Patient-level Meta-analysis2025 American Journal of Respiratory and Critical Care Medicine conference-abstract Medicine Asthma and respiratory diseases
Samuel Mailhot-Larouche, Fleur L. Meulmeester, Philippe Lachapelle, Carlos Andrés Celis-Preciado, Samuel Lemaire‐Paquette, Sanjay Ramakrishnan, +21 more
1citations